05/02/2024 6:30 AM | Janus Henderson Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/02/2024 6:30 AM | Janus Henderson Group (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/12/2024 12:42 PM | Janus Henderson Group (Issuer) SABA STEVEN (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/11/2024 8:51 AM | ARCA biopharma, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G | |
04/05/2024 11:59 AM | Beauty Health Co (Subject) Beauty Health Co (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
03/22/2024 8:01 AM | Janus Henderson Group (Filer)
| Form ARS | |
03/22/2024 8:03 AM | Janus Henderson Group (Filer)
| Form DEF 14A | |
|
03/22/2024 8:04 AM | Janus Henderson Group (Filer)
| Form DEFA14A | |
03/15/2024 7:00 AM | Janus Henderson Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 10:21 AM | Janus Henderson Group (Filed by) PRECISION BIOSCIENCES INC (Subject)
| Form SC 13G | |
03/08/2024 2:17 PM | Applied Therapeutics Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G | |
03/07/2024 4:31 PM | Hughes Brennan A. (Reporting) Janus Henderson Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 4:35 PM | Hughes Brennan A. (Reporting) Janus Henderson Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 4:39 PM | Janus Henderson Group (Issuer) ROSENBERG MICHELLE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:09 PM | Janus Henderson Group (Issuer) THOMPSON ROGER MJ (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:11 PM | FOGO GEORGINA (Reporting) Janus Henderson Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 12:43 PM | Janus Henderson Group (Filed by) Lexeo Therapeutics, Inc. (Subject)
| Form SC 13G | |
02/14/2024 12:11 PM | IDEAYA Biosciences, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G | |
02/14/2024 12:18 PM | Janus Henderson Group (Filed by) Lantheus Holdings, Inc. (Subject)
| Form SC 13G | |
02/14/2024 11:50 AM | CymaBay Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G | |
02/14/2024 11:54 AM | GoDaddy Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G | |
02/14/2024 11:37 AM | CARGO Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G | |
02/14/2024 10:33 AM | Janus Henderson Group (Filer)
| Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
02/13/2024 4:55 PM | Janus Henderson Group (Filed by) MADRIGAL PHARMACEUTICALS, INC. (Subject)
| Form SC 13G/A | |
02/13/2024 4:57 PM | Janus Henderson Group (Filed by) OmniAb, Inc. (Subject) OmniAb, Inc. (Subject) OmniAb, Inc. (Subject) OmniAb, Inc. (Subject)
| Form SC 13G/A | |
02/13/2024 4:35 PM | Janus Henderson Group (Filed by) SOLENO THERAPEUTICS INC (Subject)
| Form SC 13G/A | |
02/13/2024 4:54 PM | AVADEL PHARMACEUTICALS PLC (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 4:55 PM | Consensus Cloud Solutions, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 4:26 PM | ARDELYX, INC. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 2:32 PM | ICU MEDICAL INC/DE (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 2:39 PM | Janus Henderson Group (Filed by) LIGAND PHARMACEUTICALS INC (Subject)
| Form SC 13G/A | |
02/13/2024 2:46 PM | Janus Henderson Group (Filed by) OSI SYSTEMS INC (Subject)
| Form SC 13G/A | |
02/13/2024 2:49 PM | Janus Henderson Group (Filed by) Walker & Dunlop, Inc. (Subject)
| Form SC 13G/A | |
02/13/2024 2:53 PM | EAGLE PHARMACEUTICALS, INC. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 2:53 PM | Janus Henderson Group (Filed by) WEX Inc. (Subject)
| Form SC 13G/A | |
02/13/2024 1:51 PM | CIMPRESS plc (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 1:59 PM | CONSTELLIUM SE (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 1:10 PM | Janus Henderson Group (Filed by) Vaxcyte, Inc. (Subject)
| Form SC 13G/A | |
02/13/2024 1:18 PM | Janus Henderson Group (Filed by) ZIFF DAVIS, INC. (Subject)
| Form SC 13G/A | |
02/13/2024 1:42 PM | Beauty Health Co (Subject) Beauty Health Co (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 12:46 PM | Janus Henderson Group (Filed by) Sensata Technologies Holding plc (Subject)
| Form SC 13G/A | |
The #1 Crypto for AI (Ad) We’ve issued an urgent landmark trade alert for a new crypto wonder.
So, I decided to give you this heads-up before it’s too late.
It’s urgent because it’s what we consider “The #1 Crypto for the AI World.” Learn more about it by watching THIS NOW. |
02/13/2024 12:50 PM | Janus Henderson Group (Filed by) SENSIENT TECHNOLOGIES CORP (Subject)
| Form SC 13G/A | |
02/13/2024 12:15 PM | Janus Henderson Group (Filed by) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject)
| Form SC 13G/A | |
02/13/2024 12:34 PM | Janus Henderson Group (Filed by) Sarepta Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
02/13/2024 11:52 AM | BLACKBAUD INC (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 11:55 AM | Catalent, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 12:02 PM | FLEX LTD. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 12:08 PM | GLOBUS MEDICAL INC (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 11:47 AM | Biohaven Ltd. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 10:57 AM | Ascendis Pharma A/S (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 10:31 AM | Akero Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 10:31 AM | AMDOCS LTD (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/13/2024 9:56 AM | 4D Molecular Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/12/2024 12:42 PM | 89bio, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/12/2024 11:56 AM | Janus Henderson Group (Filed by) Mirion Technologies, Inc. (Subject) Mirion Technologies, Inc. (Subject)
| Form SC 13G/A | |
02/12/2024 11:58 AM | Biomea Fusion, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/12/2024 11:45 AM | CENTURY CASINOS INC /CO/ (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/12/2024 11:51 AM | CoreCard Corp (Subject) CoreCard Corp (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/12/2024 11:07 AM | BRADY CORP (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/12/2024 11:11 AM | Caesars Entertainment, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/12/2024 11:14 AM | CROWN HOLDINGS, INC. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/12/2024 11:17 AM | Frontdoor, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/12/2024 11:21 AM | Janus Henderson Group (Filed by) Olema Pharmaceuticals, Inc. (Subject)
| Form SC 13G/A | |
02/12/2024 11:23 AM | Janus Henderson Group (Filed by) Seres Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
02/12/2024 11:32 AM | Janus Henderson Group (Filed by) Varex Imaging Corp (Subject)
| Form SC 13G/A | |
02/12/2024 11:34 AM | Janus Henderson Group (Filed by) VISTEON CORP (Subject)
| Form SC 13G/A | |
02/12/2024 10:55 AM | Altimmune, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/12/2024 10:59 AM | BICYCLE THERAPEUTICS plc (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
02/12/2024 9:13 AM | Capital Research Global Investors (Filed by) Janus Henderson Group (Subject)
| Form SC 13G | |
02/01/2024 9:19 AM | Compass Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G | |
02/01/2024 6:30 AM | Janus Henderson Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/24/2024 1:27 PM | BlackRock Inc. (Filed by) Janus Henderson Group (Subject)
| Form SC 13G/A | |
01/18/2024 10:49 AM | IMMUNIC, INC. (Subject) IMMUNIC, INC. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G | |
12/07/2023 1:47 PM | Janus Henderson Group (Filed by) TELEFLEX INC (Subject)
| Form SC 13G | |
11/09/2023 12:59 PM | Beauty Health Co (Subject) Beauty Health Co (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/01/2023 5:06 AM | Janus Henderson Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2023 5:08 AM | Janus Henderson Group (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/10/2023 12:05 PM | Janus Henderson Group (Filed by) MADRIGAL PHARMACEUTICALS, INC. (Subject)
| Form SC 13G/A | |
10/06/2023 10:45 AM | Janus Henderson Group (Filed by) SOLENO THERAPEUTICS INC (Subject)
| Form SC 13G | |
09/08/2023 3:36 PM | Janus Henderson Group (Filed by) MADRIGAL PHARMACEUTICALS, INC. (Subject)
| Form SC 13G | |
08/18/2023 2:55 PM | Benitec Biopharma Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G | |
08/18/2023 1:45 PM | Janus Henderson Group (Filed by) Larimar Therapeutics, Inc. (Subject) Larimar Therapeutics, Inc. (Subject)
| Form SC 13G | |
08/18/2023 8:00 AM | Janus Henderson Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2023 6:15 AM | Janus Henderson Group (Filer)
| Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
08/10/2023 2:25 PM | AVADEL PHARMACEUTICALS PLC (Subject) Janus Henderson Group (Filed by)
| Form SC 13G | |
08/02/2023 5:02 AM | Janus Henderson Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/02/2023 5:07 AM | Janus Henderson Group (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/06/2023 3:26 PM | FOGO GEORGINA (Reporting) Janus Henderson Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2023 3:55 PM | AN2 Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G | |
07/05/2023 5:04 AM | Janus Henderson Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2023 4:10 PM | Janus Henderson Group (Subject) ROSENBERG MICHELLE (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Urgent Nvidia Warning (Ad) Could Steve Job's 'Final Prophecy' Make You Rich?
Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space. Click here to access… |
06/28/2023 1:59 PM | Janus Henderson Group (Filer)
| Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/23/2023 10:55 AM | Janus Henderson Group (Issuer) Seidman Leslie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 5:25 PM | Dibadj Ali (Reporting) Janus Henderson Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 12:03 PM | Bellerophon Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
06/02/2023 12:20 PM | Janus Henderson Group (Issuer) Seidman Leslie (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/02/2023 7:04 AM | Janus Henderson Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2023 7:01 AM | Janus Henderson Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/26/2023 3:41 PM | Bellerophon Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
05/26/2023 1:54 PM | Janus Henderson Group (Issuer) Sheehan Anne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |